U.S. markets close in 2 hours 44 minutes
  • S&P 500

    3,955.37
    +54.01 (+1.38%)
     
  • Dow 30

    31,817.14
    +555.24 (+1.78%)
     
  • Nasdaq

    11,461.03
    +106.41 (+0.94%)
     
  • Russell 2000

    1,790.34
    +17.08 (+0.96%)
     
  • Crude Oil

    109.93
    -0.35 (-0.32%)
     
  • Gold

    1,847.60
    +5.50 (+0.30%)
     
  • Silver

    21.71
    +0.04 (+0.17%)
     
  • EUR/USD

    1.0677
    +0.0115 (+1.09%)
     
  • 10-Yr Bond

    2.8590
    +0.0720 (+2.58%)
     
  • GBP/USD

    1.2563
    +0.0068 (+0.54%)
     
  • USD/JPY

    127.8180
    -0.0320 (-0.03%)
     
  • BTC-USD

    30,135.23
    +168.28 (+0.56%)
     
  • CMC Crypto 200

    676.57
    +1.69 (+0.25%)
     
  • FTSE 100

    7,513.44
    +123.46 (+1.67%)
     
  • Nikkei 225

    27,001.52
    +262.49 (+0.98%)
     

Aptose Biosciences: Q4 Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

TORONTO (AP) _ Aptose Biosciences Inc. (APTO) on Tuesday reported a loss of $14.7 million in its fourth quarter.

On a per-share basis, the Toronto-based company said it had a loss of 17 cents.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.

For the year, the company reported that its loss widened to $55.2 million, or 67 cents per share.

In the final minutes of trading on Tuesday, the company's shares hit $3.67. A year ago, they were trading at $5.27.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on APTO at https://www.zacks.com/ap/APTO